Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ovitrelle*


Contraindicated

Contraindicated
Ovitrelle* :
Type Medicine Non Marketed
Originator BioHuman (Ovitrelle)
Agent Food & Drug Corporation
Distributor Food & Drug Corporation
Laboratory Merck
Responsible Party Merck Serono SpA
Origin Italy
Manufacturer Merck Serono SPA
Origin Italy
ATC G03GA08

Your comment will appear shortly after approval

Ovitrelle* :

Revision Date : 31/01/2006


Effect Frequency
Abdominal pain Common
Adnexal torsion Not known
Breast pain Uncommon
Depression Uncommon
Diarrhoea (Diarrhea) Uncommon
Embolism Not known
Extra-uterine pregnancy (Ectopic pregnancy) Not known
Fatigue Common
Headache Common
Hypersensitivity Very rare
Injection site pain Common
Injection site reaction Common
Irritability Uncommon
Nausea Common
Ovarian hyperstimulation syndrome Common
Restlessness Uncommon
Skin rash Very rare
Skin reaction Very rare
Vomiting Common

Different Units By MoH Code

Revision Date : 01/03/2013

Ovitrelle* Ovitrelle* Ovitrelle* Ovitrelle* Ovitrelle* Ovitrelle* Ovitrelle*

Ovitrelle*  MoH 3555 :
Form Powder and solvent for solution for injection
Packaging Bottle
Package Size 1+1
Strength 250µg
Storage Condition 2-8°C Refrigerate
NSSF ✘
Quarantine ✘
Reg. Number 195050/04
Submission date 01/01/2004
Registration Year 2004
Archived Date 2014


Price Comparison

● Country: KSA
● Package Size: 1
● Public Price: 142.3 SAR ( 3,363,972.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 142,3 SAR ( 3,356,880.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info